F043 Data-Driven Dermatology: Mastering MIPS and Improving Practice Quality
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
As data becomes essential for measuring healthcare quality, many dermatologists face challenges with performance reporting, resulting in poorer outcomes and reduced Medicare reimbursements. This session will address the importance of engaging with performance measures, featuring tools like DataDerm to streamline reporting and benchmark success. Attendees will learn how performance measures are developed, tested, and implemented to not only meet regulatory requirements but also improve patient care and optimize practice efficiency and reimbursements.
LEARNING OBJECTIVES
Compare current measures and their effect on MIPS reimbursement.
Summarize how performance measures are developed and tested.
Demonstrate how measures can be used outside of MIPS reporting to improve patient and practice quality.
SCHEDULE
6:00 PM
Big Data in Dermatology: Shaping the Future of Quality Care
Shani Francis, MD, MBA, FAAD
6:10 PM
Building and Testing Performance Measures: Ensuring Quality in Dermatology
Christopher M DiMarco, MD, FAAD
6:35 PM
Mastering DataDerm: Leveraging MIPS and Measure Testing for Success
Steven Daniel Daveluy, MD, FAAD
7:00 PM
Unlocking the Power of Performance Measurement: Driving Dermatology Practice and Payment
Marta Jane Van Beek, MD, MPH, FAAD
7:25 PM
Patient Safety and Quality Improvement: Transforming Dermatology Care
Rita Khodosh, MD, PhD, FAAD
7:50 PM
Question and Answer Period
Shani Francis, MD, MBA, FAAD
SPEAKERS
Steven Daniel Daveluy, MD, FAAD
Christopher M DiMarco, MD, FAAD
Shani Francis, MD, MBA, FAAD
Rita Khodosh, MD, PhD, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Steven Daniel Daveluy, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Insmed – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);
Christopher M DiMarco, MD, FAAD
No financial relationships exist with ineligible companies.
Shani Francis, MD, MBA, FAAD
AbbVie – Investigator(Grants/Research Funding); American Academy of Dermatology – Advisory Board(No Compensation Received); California Society of Dermatology and Dermatologic Surgery – Board of Directors(No Compensation Received); Cronos Group – Stockholder(Stock); General Electric – Stockholder(Stock); Incyte Corporation – Investigator(Grants/Research Funding); Leo Pharma Inc. – Advisory Board(Honoraria); PerSe Beauty, Inc. – Consultant(Fees); Ralexar Therapeutics, Inc – Investigator(Grants/Research Funding);
Rita Khodosh, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.